MEDA

MEDA (3-methoxy-4,5-ethylenedioxyamphetamine) is a lesser-known psychedelic drug. MEDA was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 200 mg, and the duration unknown.[1] MEDA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.

This article is about the psychedelic drug. For the instrument on the Perseverance rover, see Mars Environmental Dynamics Analyzer.
MEDA
Names
Preferred IUPAC name
1-(8-Methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.032.914
KEGG
UNII
  • InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3 N
    Key: NRVFDGZJTPCULU-UHFFFAOYSA-N Y
  • InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3
    Key: HEYPARQBPGSFKW-UHFFFAOYSA-N
  • NC(CC1=CC2=C(OCCO2)C(OC)=C1)C
Properties
C12H17NO3
Molar mass 223.272 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YN ?)
Infobox references

See also

References
  1. MEDA entry in PiHKAL


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.